Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neoplasms
|
1644 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.040 | 1.000 | 4 | 2008 | 2019 | |||||
Esophageal carcinoma
|
272 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||
Esophageal Neoplasms
|
270 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||
Malignant neoplasm of esophagus
|
214 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||
Anemia, severe
|
6 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Endometriosis
|
274 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Childhood Osteosarcoma
|
151 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.833 | 12 | 2012 | 2018 | |||||
Osteosarcoma
|
178 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.833 | 12 | 2012 | 2018 | |||||
Osteosarcoma of bone
|
151 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.833 | 12 | 2012 | 2018 | |||||
Breast Carcinoma
|
2793 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.090 | 0.889 | 9 | 2004 | 2018 | |||||
Malignant neoplasm of breast
|
3417 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.090 | 0.889 | 9 | 2004 | 2018 | |||||
Malignant neoplasm of prostate
|
1082 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.070 | 0.857 | 7 | 2004 | 2018 | |||||
Prostate carcinoma
|
1168 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.070 | 0.857 | 7 | 2004 | 2018 | |||||
melanoma
|
515 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2005 | 2018 | |||||
Diffuse Large B-Cell Lymphoma
|
127 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 0.500 | 2 | 2013 | 2018 | |||||
progesterone receptor-negative breast cancer
|
11 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
progesterone receptor-positive breast cancer
|
17 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant Neoplasms
|
1641 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.909 | 11 | 2002 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.900 | 10 | 2002 | 2017 | |||||
Malignant neoplasm of stomach
|
615 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.090 | 0.889 | 9 | 2011 | 2017 | |||||
Glioma
|
353 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.040 | 0.500 | 4 | 2012 | 2017 | |||||
Lymphoma, Non-Hodgkin
|
197 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.040 | 0.750 | 4 | 2009 | 2017 | |||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
Childhood Non-Hodgkin Lymphoma
|
39 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
Lymphoma, Non-Hodgkin, Familial
|
79 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2014 | 2017 |